MeiraGTx Holdings PLC

MGTX Healthcare Biotechnology

MeiraGTx Holdings PLC’s revenue for fiscal 2025 (year ended December 2025) was $81.4 million, up 144.6% from fiscal 2024. In the quarter to June 2026, revenue grew 8,608.6%, EPS grew 466.7%, free cash flow grew 13.1% and total debt rose 28.6%, each against the same quarter a year earlier.

9.28 0.61 −6.17%
Market cap
$949.9M
P/E
12.2×
Fwd P/E
−5.6×
Dividend yield
—
F-score
5/9
Altman Z
−4.39
Beneish M
−3.01
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
72.22% 963.07% (368.19%) (611.42%)

+8 more TTM periods

Piotroski F-Score
6 6 5 4
ROA
26.54% (51.44%) (44.42%) (69.00%)
ROIC
66.60% 0.00% 0.00% 0.00%
Return on Tangible Assets
30.31% (532.23%) (152.94%) 1,520.40%
Average Days of Receivables
40.64 82.19 82.00 157.23
Free Cash Flow per Share
0.11 0.05 (0.62) (1.49)
Free Cash Flow
10.12 4.28 (50.06) (120.50)
Capital Expenditures
(3.57) (3.99) (3.70) (4.24)
Other line items
Cash ROIC
2.21% 6.78% (45.53%) 849.50%
Accounts Receivable Turnover
15.57 6.96 5.82 2.71
Accounts Payable Turnover
0.44 0.20 0.29 0.63
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
522.49 1,659.89 758.64 486.06
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
(0.03) 0.00 0.00 0.00
Research and Development Expense of Revenue
38.53% 161.52% 159.25% 447.87%
Selling, General and Administrative Expense of Revenue
13.12% 65.78% 64.99% 191.06%
Share Based Compensation of Revenue
4.78% 26.17% 27.16% 82.51%
Interest Coverage
14.75 (8.76) (8.69) (13.06)
Operating CF/Net income
0.17 (0.07) 0.41 0.69
Depreciation/Fixed assets
0.13 0.13 0.13 0.13
Capex/Depreciation
(0.26) (0.29) (0.27) (0.31)
Revenue per Share
4.35 0.98 1.01 0.34
Operating CF per Share
0.15 0.10 (0.58) (1.44)
Capex per Share
(0.04) (0.05) (0.05) (0.05)
Capex to Sales
0.01 0.05 0.05 0.15

Fold the line items

Columns are period end dates